• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR Back to Search Results
Catalog Number UNK CDS
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fatigue (1849); Mitral Valve Insufficiency/ Regurgitation (4451)
Event Date 05/01/2014
Event Type  Injury  
Event Description
This is filed to report worsened mitral regurgitation.The aim of this prospective observational study was to analyze the contribution of heart failure to the physical frailty phenotype by examining patients with heart failure before and after percutaneous mitral valve repair (pmvr) with a mitraclip or non-abbott device.Frailty according to the fried criteria (weight loss, weakness, exhaustion, slowness, and low activity) was assessed in consecutive patients before and 6 weeks after pmvr.All patients had symptomatic mitral regurgitation (mr) grade 3 or 4, and the etiology was primary cause in 88 patients, of secondary cause in 141 patients, and of mixed causes in 28 patients.It was noted that 25% of the patients died within 90 days after the procedure and 12% were newly frail post-pmvr.There was an increase of patients with post-procedure mr grade of 3-4 ( baseline: 7 no-nfrail and 4 frail; follow-up: 9 non-frail and 6 frail).Treatment of mitral regurgitation in patients with heart failure is associated with almost a halved burden of physical frailty, particularly in patients with a less advanced phenotype.This study warrants further evaluation of the concept of frailty as a primary treatment target.Details are listed in the article titled, "disentangling heart failure and physical frailty prospective study of patients undergoing percutaneous mitral valve repair.".
 
Manufacturer Narrative
The additional patient effect of death reported in the article is captured under a separate medwatch report.B3: date of event was estimated.D4: the udi is unknown as the part and lot numbers were not provided d6a: date of implant was estimated.The device was not returned for analysis.The lot history record (lhr) review was not performed because this incident was based on an article review and no lot information was provided.Based on available information, the cause of the reported fatigue, death / expired, and mitral valve insufficiency/ regurgitation (worsening mr) could not be determined.The reported patient effects of death and mitral regurgitation, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP® SYSTEM CLIP DELIVERY SYSTEM
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key17182585
MDR Text Key317994310
Report Number2135147-2023-02714
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 06/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK CDS
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/01/2023
Initial Date FDA Received06/22/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age78 YR
Patient SexFemale
-
-